U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT06875700) titled 'Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients' on March 07.
Brief Summary: Genomic research has shown that a portion of leiomyosarcomas can be attributed to an underlying cancer predisposition syndrome. However, the optimal approach for incorporating germline testing into the care of these patients. This study is assessing the beliefs about the heritability of leiomyosarcoma and other cancer risks, and attitudes towards germline testing among leiomyosarcoma patients.
Study Start Date: July 09, 2024
Study Type: OBSERVATIONAL
Condition:
Leiomyosarcoma
Recruitment Status: RECRUITING
Sponsor: University o...